University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (5) — La Jolla, California

University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (5) is a clinical research site located in La Jolla, California, United States 92093-0658.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (5) has participated in 2 clinical trials.

Therapeutic areas: Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (5)?

University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (5) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (5) conducted?

University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (5) has 2 clinical trials on record. Their work covers Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma.

Is University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (5) accredited by Crixeo Health?

University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (5) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (5)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.